Suppr超能文献

自发性高血压大鼠在钙通道阻滞剂给药和停药后的快速大动脉重构。

Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.

机构信息

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia.

出版信息

Eur J Pharmacol. 2009 Oct 1;619(1-3):85-91. doi: 10.1016/j.ejphar.2009.08.003. Epub 2009 Aug 14.

Abstract

Chronic treatment with several antihypertensive agents, including calcium channel blockers, may interfere with remodeling of large arteries and increased arterial stiffness. We hypothesize that even a short, seven-day administration of calcium channel blockers might alter an aortic remodeling in spontaneously hypertensive rat (SHR). Male SHR and normotensive WKY rats (n=14 each) were treated by either vehicle, vasculoselective calcium channel blocker nifedipine (1mg/kg/day) or cardiac/vascular calcium channel blockers diltiazem (5mg/kg/day) or verapamil (4 mg/kg/day, n=6 for each treatment) subcutaneously twice daily for seven days. Additional SHR rats were randomized for termination 24, 72 or 120 h (n=5 each) after the withdrawal of nifedipine. Systolic blood pressure was measured by tail cuff and thoracic aorta was collected for histomorphometric and functional analysis including acetylcholine-induced endothelium-dependent relaxation. Seven-day administration of diltiazem and nifedipine, but not verapamil decreased blood pressure in SHR. All drugs significantly attenuated abnormal aortic wall thickness, cross-sectional area and media-to-lumen ratio, but only nifedipine improved impaired endothelium-dependent relaxation. Following the withdrawal of nifedipine, all measured parameters returned back to control SHR values within 72 h. Seven-day treatment with distinct calcium channel blockers attenuates hypertensive remodeling of aorta, which might be, in case of nifedipine, reactivated even by a very short withdrawal of the drug. Therefore, vasculoprotection by calcium channel blockers is not restricted to a prolonged blood pressure modulation, but occurs rapidly. These findings could be relevant for an intervention in augmented vascular stiffness and related cardiovascular risk.

摘要

慢性使用多种降压药物,包括钙通道阻滞剂,可能会干扰大动脉的重构和动脉僵硬度的增加。我们假设,即使是短期的,七天的钙通道阻滞剂治疗也可能改变自发性高血压大鼠(SHR)的主动脉重构。雄性 SHR 和正常血压 WKY 大鼠(每组 14 只)分别接受vehicle、血管选择性钙通道阻滞剂硝苯地平(1mg/kg/天)、心脏/血管钙通道阻滞剂地尔硫卓(5mg/kg/天)或维拉帕米(4mg/kg/天,每组 6 只)皮下注射,每天两次,共七天。另外的 SHR 大鼠随机分为硝苯地平停药后 24、72 或 120 小时(每组 5 只)终止组。通过尾套测量收缩压,并收集胸主动脉进行组织形态学和功能分析,包括乙酰胆碱诱导的内皮依赖性舒张。七天的地尔硫卓和硝苯地平治疗可降低 SHR 的血压,但维拉帕米没有。所有药物均显著减轻主动脉壁厚度、横截面积和中腔比的异常,但只有硝苯地平改善了受损的内皮依赖性舒张。硝苯地平停药后,所有测量参数在 72 小时内恢复到对照 SHR 值。不同的钙通道阻滞剂治疗 7 天可减轻高血压大鼠的主动脉重构,硝苯地平停药后,即使停药很短时间,这种重构也可能重新激活。因此,钙通道阻滞剂的血管保护作用不仅限于长期的血压调节,而是迅速发生。这些发现可能与增强血管僵硬和相关心血管风险的干预有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验